(S)-tert-Butyl 2-(5-(4-bromophenyl)-1H-imidazol-2-yl)pyrrolidine-1-carboxylate
- CAS
- 1007882-04-3
- Formula
- C18H22BrN3O2
- MW
- 392.3 g/mol
VQ-047918
Impurity reference standards
Daclatasvir impurities & reference standards
Characterised Daclatasvir impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
25reference materials
1isotope-labelled
COAHPLC · NMR · MS on request
Daclatasvir EP Impurity H (tetrahydrochloride)
- CAS
- 1009119-83-8
- Formula
- C26H32Cl4N6
- MW
- 570.4 g/mol
In stock
FAQs — Daclatasvir impurities
Which Daclatasvir impurities do you supply?
We list 25 Daclatasvir-related reference materials, including process impurities, degradation products, stable-isotope-labelled standards and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Daclatasvir impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Daclatasvir impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Daclatasvir impurity standards
We reply within one business day with price, pack options, lead time and documentation.